| 2101 |
Cord Tissue |
Allogeneic – Unrelated |
Non-Inflammatory Diseases Of The Ovary, Fallopian Tube, And Broad Ligament Of The Uterus |
Gynecology |
2023 |
Experimental Therapy |
Poland |
47 |
| 2102 |
Cord Tissue |
Autologous |
Optic Nerve Atrophy, Tetraparesis, Hydrocephalus |
Neurology |
2023 |
Experimental Therapy |
Romania |
5,5 |
| 2103 |
Cord Tissue |
Allogeneic – Unrelated |
Ovarian Dysfunction |
Gynecology |
2023 |
Experimental Therapy |
Poland |
44,8 |
| 2104 |
Cord Tissue |
Allogeneic – Unrelated |
Ovarian Dysfunction |
Gynecology |
2023 |
Experimental Therapy |
Poland |
32,11 |
| 2105 |
Cord Tissue |
Allogeneic – Unrelated |
Polycystic Ovary Syndrome |
Gynecology |
2023 |
Experimental Therapy |
Poland |
39,4 |
| 2106 |
Cord Tissue |
Allogeneic – Related |
Right Parietal Closed Schizencephaly |
Neurology |
2023 |
Experimental Therapy |
Romania |
38 |
| 2107 |
Cord Tissue |
Allogeneic – Related |
Rp+ Usher Syndrome |
Neurology |
2023 |
Experimental Therapy |
Romania |
10 |
| 2108 |
Cord Tissue |
Allogeneic – Related |
Sudden Sensorineural Hearing Loss (Ssnhl) |
Neurology |
2023 |
Experimental Therapy |
Romania |
1 |
| 2109 |
Cord Blood |
Autologous |
Autism |
Neurology |
2023 |
Experimental Therapy |
Hungary |
10 |
| 2110 |
Cord Blood |
Allogeneic |
Autism |
Neurology |
2023 |
Experimental Therapy |
Poland |
3,3 |
| 2111 |
Cord Blood |
Autologous |
Autism |
Neurology |
2023 |
Experimental Therapy |
Romania |
3 |
| 2112 |
Cord Blood |
Autologous |
Autism |
Neurology |
2023 |
Experimental Therapy |
Romania |
3 |
| 2113 |
Cord Blood |
Autologous |
Autism |
Neurology |
2023 |
Experimental Therapy |
Romania |
10 |
| 2114 |
Cord Blood |
Autologous |
Autism |
Neurology |
2023 |
Experimental Therapy |
Portugal |
7 |
| 2115 |
Cord Blood |
Autologous |
Autism |
Neurology |
2023 |
Experimental Therapy |
Portugal |
5 |
| 2116 |
Cord Blood |
Autologous |
Autism |
Neurology |
2023 |
Experimental Therapy |
Hungary |
14 |
| 2117 |
Cord Blood |
Autologous |
Autism |
Neurology |
2023 |
Experimental Therapy |
Romania |
10 |
| 2118 |
Cord Blood |
Autologous |
Autism |
Neurology |
2023 |
Experimental Therapy |
Hungary |
3 |
| 2119 |
Cord Blood |
Allogeneic – Related |
Autism |
Neurology |
2023 |
Experimental Therapy |
Romania |
3,2 |
| 2120 |
Cord Blood |
Autologous |
Autism |
Neurology |
2023 |
Experimental Therapy |
Hungary |
5 |
| 2121 |
Cord Blood |
Allogeneic – Related |
Beta Thalassemia |
Hematology |
2023 |
Standard Therapy |
UK |
8 |
| 2122 |
Cord Blood |
Allogeneic – Related |
Cerebral Palsy |
Neurology |
2023 |
Experimental Therapy |
Hungary |
5 |
| 2123 |
Cord Blood |
Allogeneic – Related |
Cerebral Palsy |
Neurology |
2023 |
Standard Therapy |
UK |
2,5 |
| 2124 |
Cord Blood |
Allogeneic – Related |
Cerebral Palsy |
Neurology |
2023 |
Standard Therapy |
UK |
2,5 |
| 2125 |
Cord Blood |
Autologous |
Cerebral Palsy |
Neurology |
2023 |
Experimental Therapy |
Poland |
2,1 |
| 2126 |
Cord Blood |
Allogeneic – Related |
Cerebral Palsy |
Neurology |
2023 |
Experimental Therapy |
Romania |
10 |
| 2127 |
Cord Blood |
Allogeneic – Related |
Cerebral Palsy, Psychomotor Retard, Tetraparesis, Microcephaly |
Neurology |
2023 |
Experimental Therapy |
Romania |
9 |
| 2128 |
Cord Blood |
Autologous |
Global Developmental Delay Si Truncal Ataxia |
Neurology |
2023 |
Experimental Therapy |
Romania |
5 |
| 2129 |
Cord Blood |
Allogeneic |
Neuroblastoma |
Hematology |
2023 |
Standard Therapy |
Turkey |
2,1 |
| 2130 |
Cord Blood |
Allogeneic – Related |
Neuroblastoma |
Hematology |
2023 |
Standard Therapy |
Turkey |
2,1 |
| 2131 |
Cord Blood |
Autologous |
Optic Nerve Atrophy, Tetraparesis, Hydrocephalus |
Neurology |
2023 |
Experimental Therapy |
Romania |
5,5 |
| 2132 |
Cord Blood |
Autologous |
Pervasive Developmental Disorder |
Neurology |
2023 |
Experimental Therapy |
Poland |
3,11 |
| 2133 |
Cord Blood |
Autologous |
Pervasive Developmental Disorder |
Neurology |
2023 |
Experimental Therapy |
Poland |
8,1 |
| 2134 |
Cord Blood |
Allogeneic – Related |
Spasmodic Torticollis |
Neurology |
2023 |
Experimental Therapy |
Romania |
41 |
| 2135 |
Cord Blood |
Allogeneic |
Thalassemia Major |
Hematology |
2023 |
Standard Therapy |
Turkey |
17,4 |
| 2136 |
Cord Blood |
Allogeneic – Related |
Thalassemia Major |
Hematology |
2023 |
Standard Therapy |
Turkey |
17,4 |
| 2137 |
Cord Blood |
Allogeneic |
Wiskott-Aldrich Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
5 months |
| 2138 |
Cord Blood |
Autologous |
Autism |
Neurology |
2023 |
Experimental Therapy |
Slovakia |
2 |
| 2139 |
Bone Marrow Family |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
42 |
| 2140 |
Bone Marrow Family |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
41 |
| 2141 |
Bone Marrow Family |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
35 |
| 2142 |
Bone Marrow Family |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
59 |
| 2143 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
50 |
| 2144 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
51 |
| 2145 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
59 |
| 2146 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
42 |
| 2147 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
21 |
| 2148 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
67 |
| 2149 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
63 |
| 2150 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
39 |
| 2151 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
53 |
| 2152 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
42 |
| 2153 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
62 |
| 2154 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
49 |
| 2155 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
61 |
| 2156 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
43 |
| 2157 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
57 |
| 2158 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
56 |
| 2159 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
55 |
| 2160 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
63 |
| 2161 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
55 |
| 2162 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
61 |
| 2163 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
47 |
| 2164 |
Bone Marrow Family |
Allogeneic |
B-Cell Precursor Acute Lymphocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
30 |
| 2165 |
Bone Marrow Family |
Allogeneic |
Chronic Lymphocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
69 |
| 2166 |
Bone Marrow Family |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
60 |
| 2167 |
Bone Marrow Family |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
70 |
| 2168 |
Bone Marrow Family |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
76 |
| 2169 |
Bone Marrow Family |
Allogeneic |
Langerhans Cell Sarcoma |
Hematology |
2023 |
Standard Therapy |
Poland |
66 |
| 2170 |
Bone Marrow Family |
Allogeneic |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Poland |
63 |
| 2171 |
Bone Marrow Family |
Allogeneic |
Mycosis Fungoides |
Hematology |
2023 |
Standard Therapy |
Poland |
71 |
| 2172 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
71 |
| 2173 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
68 |
| 2174 |
Bone Marrow Family |
Allogeneic |
Myelofibrosis |
Hematology |
2023 |
Standard Therapy |
Poland |
70 |
| 2175 |
Bone Marrow Family |
Allogeneic |
No Data |
Hematology |
2023 |
Standard Therapy |
Germany |
70 |
| 2176 |
Bone Marrow Family |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2023 |
Standard Therapy |
Poland |
55 |
| 2177 |
Bone Marrow Family |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
73 |
| 2178 |
Bone Marrow Family |
Allogeneic |
Secondary Chronic Myelomonocytic Leukemia To Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
62 |
| 2179 |
Bone Marrow Family |
Allogeneic |
Secondary Myelodysplastic Syndrome With Excess Of Blasts |
Hematology |
2023 |
Standard Therapy |
Poland |
15 |
| 2180 |
Bone Marrow Family |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
71 |
| 2181 |
Bone Marrow Family |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
5 |
| 2182 |
Bone Marrow |
Allogeneic |
Acute Leukemia Of Ambiguous Lineage |
Hematology |
2023 |
Standard Therapy |
Poland |
1 |
| 2183 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
11 |
| 2184 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
5 |
| 2185 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
16 |
| 2186 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
28 |
| 2187 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
14 |
| 2188 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
1 |
| 2189 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
25 |
| 2190 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
7 |
| 2191 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
4 |
| 2192 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
8 months |
| 2193 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
12 |
| 2194 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
63 |
| 2195 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
5 |
| 2196 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
12 |
| 2197 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
3 |
| 2198 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
49 |
| 2199 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
14 |
| 2200 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
47 |